CLASS II Drug recall · Reported 26 Aug 2020 · FDA Enforcement Report
Phentermine HCL Blue/White Capsules, 37.5 mg recalled
Calvin Scott is recalling Phentermine HCL Blue/White Capsules, 37.5 mg, distributed nationwide in the US. The recall was initiated on 27 Jul 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1529-2020
- FDA event ID
- 86123
- Recalling firm
- Calvin Scott, Albuquerque, NM
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 27 Jul 2020
- FDA classified
- 20 Aug 2020
- Reported
- 26 Aug 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 27 Jul 2020 | Recall initiated by company | |
| 20 Aug 2020 | Classified by FDA | +24 days |
| 26 Aug 2020 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Product as listed by the FDA
Phentermine HCL Blue/White Capsules, 37.5 mg, 28-count bags, Rx only, Distributed by: Calvin Scott & Co., Inc. Albuquerque, NM 87123, MFG: KVK-Tech., Inc Newtown, PA 18940; NDC 10702-0029-10
Where it was distributed
Nationwide within the United States
Questions about this recall
Why was it recalled?
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Which lots are affected?
Lot #:19219; Exp. Date: 08/20
Where was it sold?
Nationwide within the United States
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
18 other products · FDA event 86123This product is part of a recall event; the main page for the event is Phentermine 15mg grey/Yellow Capsules recalled by Calvin Scott & Company.
More recalls from Calvin Scott
All 24| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Benzphetamine tablets, 50mg, CIII recalled by Calvin Scott & Company | Calvin Scott | Packaging Defects | GA |
| Drug | CLASS I | Benzonatate capsules, 100mg recalled by Calvin Scott & Company | Calvin Scott | Packaging Defects | GA |
| Drug | CLASS II | Diethylpropion, 75 mg tablets, Rx only recalled | Calvin Scott | Potency & Assay | 5 states |
| Drug | CLASS II | Phentermine, 30 mg capsules, Rx only recalled by Calvin Scott & Company | Calvin Scott | Potency & Assay | 5 states |
| Drug | CLASS II | Diethylpropion, 25 mg tablets, Rx only recalled | Calvin Scott | Potency & Assay | 5 states |
Other Phentermine Blue recalls
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Phentermine HCL Blue/Clear capsules, 30mg recalled | Calvin Scott | Manufacturing (CGMP) Deviations | Nationwide |